Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 13 | 28399484 | intron variant | G/A | snv | 0.30 |
|
Cardiovascular Diseases | 0.800 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.925 | 0.040 | 13 | 28409926 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.040 | 13 | 28448508 | intron variant | C/T | snv | 0.32 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
13 | 28360227 | intron variant | C/T | snv | 0.23 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.040 | 13 | 28423565 | intron variant | G/A | snv | 0.30 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.160 | 13 | 28312790 | intron variant | A/C;G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2014 | 2017 | ||||||||
|
0.882 | 0.160 | 13 | 28312790 | intron variant | A/C;G | snv |
|
0.030 | 1.000 | 3 | 2014 | 2017 | |||||||||
|
0.776 | 0.280 | 13 | 28311271 | intron variant | C/A | snv | 0.59 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||||
|
0.776 | 0.280 | 13 | 28311271 | intron variant | C/A | snv | 0.59 |
|
0.030 | 1.000 | 3 | 2014 | 2017 | ||||||||
|
0.925 | 0.040 | 13 | 28409926 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
1.000 | 0.040 | 13 | 28420518 | intron variant | T/C | snv | 0.42 |
|
Eye Diseases | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||||
|
1.000 | 0.040 | 13 | 28483931 | intron variant | A/C | snv | 0.44 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 13 | 28431232 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 13 | 28326373 | intron variant | C/T | snv | 5.0E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 13 | 28358693 | intron variant | T/A;G | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.200 | 13 | 28319347 | intron variant | T/C | snv | 0.70 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.200 | 13 | 28319347 | intron variant | T/C | snv | 0.70 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
13 | 28319505 | synonymous variant | A/C;G | snv | 8.0E-06; 0.21 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.040 | 13 | 28389565 | 3 prime UTR variant | G/A | snv | 0.42 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 13 | 28389988 | missense variant | G/A;C;T | snv | 4.4E-05; 4.0E-06; 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 13 | 28432710 | intron variant | C/T | snv | 0.77 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
13 | 28439277 | intron variant | G/A;C | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
13 | 28439277 | intron variant | G/A;C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
13 | 28489832 | intron variant | G/A | snv | 0.61 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
0.851 | 0.080 | 13 | 28496864 | non coding transcript exon variant | T/A;C | snv |
|
Respiratory Tract Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 |